Venus-Vitae Pivotal Study Smart-Align Study

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2029

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Venus-Vitae Transcatheter Heart Valve System

The Venus-Vitae THV is comprised of balloon-expandable and radiopaque cobalt-chromium alloy frame, porcine pericardium tri-leaflet, porcine pericardium inner skirt, polyurethane outer skirt, PTFE assembly sutures, and three radiopaque gold markers (Figure 1). The valve utilizes Venus Endura technology and stored in a non-aqueous condition.

All Listed Sponsors
lead

Venus MedTech (HangZhou) Inc.

INDUSTRY